HALB (Halberd) FCF Yield % : -14.58 (As of Mar. 26, 2025)

View and export this data going back to 2009. Start your Free Trial

What is Halberd FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Halberd's Trailing 12-Month Free Cash Flow is $-0.24 Mil, and Market Cap is $1.65 Mil. Therefore, Halberd's FCF Yield % for today is -14.58%.

The historical rank and industry rank for Halberd's FCF Yield % or its related term are showing as below:

HALB' s FCF Yield % Range Over the Past 10 Years
Min: -211.4 Med: 0 Max: 0
Current: -14.58

HALB's FCF Yield % is ranked worse than
50.23% of 1501 companies
in the Biotechnology industry
Industry Median: -14.49 vs HALB: -14.58

Halberd's FCF Margin % for the quarter that ended in Jul. 2023 was -8,033.33%.

Halberd FCF Yield % Historical Data

The historical data trend for Halberd's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd FCF Yield % Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

FCF Yield %

-14.45

-4.39

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
FCF Yield %	-	-14.45	-4.39

Competitive Comparison of Halberd's FCF Yield %

For the Biotechnology subindustry, Halberd's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Halberd's FCF Yield % falls into.

Halberd FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Halberd's FCF Yield % for the fiscal year that ended in Jul. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.241	/	5.4889875
	=	-4.39%

Halberd's annualized FCF Yield % for the quarter that ended in Jul. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.241	*	1	/	5.4889875
	=	-4.39%

Halberd FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Halberd FCF Yield % Related Terms

Thank you for viewing the detailed overview of Halberd's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236